All News #Library
Others
Cornerstone Pharma Announces Published Data on CPI-613 as an Effective Approach
16 Jun 2022 //
GLOBENEWSWIRE
Cornerstone to Present Pancreatic Cancer, CCS & BTC Research Featuring CPI-613
01 Jun 2022 //
GLOBENEWSWIRE
EMA Grants ODD to Cornerstone`s CPI-613 (Devimistat) for Biliary Tract Cancer
24 May 2022 //
GLOBENEWSWIRE
Cornerstone Pharma Announces Corporate Name Change to Rafael Pharm
06 Jun 2017 //
GLOBENEWSWIRE